Bellevue Group Ag Blueprint Medicines Corp Transaction History
Bellevue Group Ag
- $5.93 Billion
- Q3 2024
A detailed history of Bellevue Group Ag transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Bellevue Group Ag holds 3,200 shares of BPMC stock, worth $283,808. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,200
Previous 5,100
37.25%
Holding current value
$283,808
Previous $549,000
46.27%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding BPMC
# of Institutions
350Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$593 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$590 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$478 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$352 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$245 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.3B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...